Description
| Strength | 50 mg |
| Brand Name | Phosome |
| Manufacturer | Cipla |
| Packaging Type | Box |
| Usage/Application | Treatment Of Severe Fungal Infections And Leishmaniasis |
| Shelf Life | 24 Months |
| Composition | Liposomal Amphotericin B |
| Form | Injection |
Product’s Details:
- Phosome 50 mg (Liposomal Amphotericin B Injection) is a lipid-based formulation designed to minimize nephrotoxicity and infusion-related adverse effects commonly associated with conventional Amphotericin B. It is indicated for the treatment of severe systemic fungal infections and visceral leishmaniasis, offering improved safety and efficacy.
- Composition: Each vial contains 50 mg of Liposomal Amphotericin B for intravenous administration.
- Features & Benefits:
- Effective against a wide range of systemic fungal infections
- Reduced nephrotoxicity compared to conventional Amphotericin B
- Lower incidence of infusion-related side effects
- Standard treatment for visceral leishmaniasis
- Backed by proven clinical safety and efficacy
- Side Effects: Common side effects may include:
- Fever, chills, or rigors during infusion
- Nausea and vomiting
- Electrolyte imbalance (hypokalemia, hypomagnesemia)
- Elevated creatinine (less common than conventional Amphotericin B)
Severe (rare) side effects:
- Nephrotoxicity (significantly reduced with liposomal form)
- Rare infusion-related reactions
- Occasional hepatotoxicity
- Rare anaphylactic reactions
- Storage:
- Store below 25°C
- Protect from light
- Do not freeze
- Use immediately after reconstitution
- Reconstituted solution should be used within 24 hours if refrigerated
Reviews
There are no reviews yet.